BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2989517)

  • 1. Isoxazoles with antipicornavirus activity.
    Diana GD; McKinlay MA; Brisson CJ; Zalay ES; Miralles JV; Salvador UJ
    J Med Chem; 1985 Jun; 28(6):748-52. PubMed ID: 2989517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating.
    Diana GD; McKinlay MA; Otto MJ; Akullian V; Oglesby C
    J Med Chem; 1985 Dec; 28(12):1906-10. PubMed ID: 2999407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
    Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
    Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipicornavirus activity of tetrazole analogues related to disoxaril.
    Diana GD; Cutcliffe D; Volkots DL; Mallamo JP; Bailey TR; Vescio N; Oglesby RC; Nitz TJ; Wetzel J; Giranda V
    J Med Chem; 1993 Oct; 36(22):3240-50. PubMed ID: 8230114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WIN 51711, a new systematically active broad-spectrum antipicornavirus agent.
    McKinlay MA
    J Antimicrob Chemother; 1985 Sep; 16(3):284-6. PubMed ID: 4055541
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus.
    Diana GD; Cutcliffe D; Oglesby RC; Otto MJ; Mallamo JP; Akullian V; McKinlay MA
    J Med Chem; 1989 Feb; 32(2):450-5. PubMed ID: 2913305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
    Woods MG; Diana GD; Rogge MC; Otto MJ; Dutko FJ; McKinlay MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2069-74. PubMed ID: 2559655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of picornavirus uncoating as antiviral agents.
    Diana GD; Otto MJ; McKinlay MA
    Pharmacol Ther; 1985; 29(3):287-97. PubMed ID: 3014575
    [No Abstract]   [Full Text] [Related]  

  • 9. Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan.
    Quaglia MG; Desideri N; Bossù E; Sestili I; Tomao P; Conti C; Orsi N
    Chirality; 1993; 5(5):356-8. PubMed ID: 8398593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipicornavirus activity of substituted phenoxybenzenes and phenoxypyridines.
    Markley LD; Tong YC; Dulworth JK; Steward DL; Goralski CT; Johnston H; Wood SG; Vinogradoff AP; Bargar TM
    J Med Chem; 1986 Mar; 29(3):427-33. PubMed ID: 3005578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.
    Diana GD; Kowalczyk P; Treasurywala AM; Oglesby RC; Pevear DC; Dutko FJ
    J Med Chem; 1992 Mar; 35(6):1002-8. PubMed ID: 1313108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
    Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
    Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studies.
    Cox S; Buontempo PJ; Wright-Minogue J; DeMartino JL; Skelton AM; Ferrari E; Schwartz J; Rozhon EJ; Linn CC; Girijavallabhan V; O'Connell JF
    Antiviral Res; 1996 Oct; 32(2):71-9. PubMed ID: 8891166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipicornavirus flavone Ro 09-0179.
    Ishitsuka H; Ohsawa C; Ohiwa T; Umeda I; Suhara Y
    Antimicrob Agents Chemother; 1982 Oct; 22(4):611-6. PubMed ID: 6295260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [(Biaryloxy)alkyl]isoxazoles: picornavirus inhibitors.
    Guiles JW; Diana GD; Pevear DC
    J Med Chem; 1995 Jul; 38(14):2780-3. PubMed ID: 7629816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral agents against picornaviruses.
    Eggers HJ
    Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
    [No Abstract]   [Full Text] [Related]  

  • 18. A model for compounds active against human rhinovirus-14 based on X-ray crystallography data.
    Diana GD; Treasurywala AM; Bailey TR; Oglesby RC; Pevear DC; Dutko FJ
    J Med Chem; 1990 May; 33(5):1306-11. PubMed ID: 2158559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating.
    Diana GD; Oglesby RC; Akullian V; Carabateas PM; Cutcliffe D; Mallamo JP; Otto MJ; McKinlay MA; Maliski EG; Michalec SJ
    J Med Chem; 1987 Feb; 30(2):383-8. PubMed ID: 3027340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antirhinoviral activity of heterocyclic analogs of Win 54954.
    Bailey TR; Diana GD; Kowalczyk PJ; Akullian V; Eissenstat MA; Cutcliffe D; Mallamo JP; Carabateas PM; Pevear DC
    J Med Chem; 1992 Nov; 35(24):4628-33. PubMed ID: 1335079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.